 | |||||||
| lose weight | |||||||
| NEWS | |||||||
Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC Amgen CEO Bob Bradway discussed his company's weight loss drug in an interview with CNBC's Jim Cramer.
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
